The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis.
The use of GTX as second-line and later chemotherapy for metastatic pancreatic cancer: a retrospective analysis. Cancer Chemother Pharmacol. 2012 Feb; 69(2):425-30.